Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Genelux Corp. ( (GNLX) ) has shared an announcement.
Genelux Corporation announced the resignation of Lourie Zak as Chief Financial Officer on January 29, 2025. As part of her departure, Zak will serve as a non-employee advisor until August 29, 2025, and receive severance benefits including a cash payment, health insurance continuation, and eligibility for an annual bonus. Concurrently, Matt Pulisic was appointed as the new CFO, effective January 30, 2025. Pulisic, previously with Arrowhead Pharmaceuticals, will receive a base salary with a discretionary bonus, stock options, and severance benefits under certain conditions, strengthening the company’s financial leadership.
More about Genelux Corp.
YTD Price Performance: 63.90%
Average Trading Volume: 191,894
Technical Sentiment Consensus Rating: Hold
Current Market Cap: $136.4M
For an in-depth examination of GNLX stock, go to TipRanks’ Stock Analysis page.